ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $26,463,000 | +22.8% | 545,976 | +7.1% | 0.18% | -4.2% |
| Q1 2020 | $21,543,000 | +162.5% | 509,885 | +113.6% | 0.19% | +171.4% |
| Q1 2017 | $8,206,000 | +2082.4% | 238,694 | +1674.7% | 0.07% | +2233.3% |
| Q1 2016 | $376,000 | -99.3% | 13,450 | -99.1% | 0.00% | -99.2% |
| Q4 2015 | $52,744,000 | +1.2% | 1,479,504 | -35.9% | 0.36% | +14.5% |
| Q2 2014 | $52,144,000 | -8.7% | 2,308,261 | -1.7% | 0.31% | -9.4% |
| Q1 2014 | $57,113,000 | -23.1% | 2,347,411 | -21.0% | 0.34% | -21.7% |
| Q4 2013 | $74,246,000 | +31.2% | 2,971,041 | +44.2% | 0.44% | +20.7% |
| Q3 2013 | $56,603,000 | – | 2,060,551 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |